Background. Two doses of either trivalent live attenuated or inactivated influenza vaccines (LAIV
and TIV, respectively) are approved for young children (≥24 months old for LAIV and ≥…

Vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection wanes over time, requiring updated boosters. In a phase 2, open-label, …

Mycobacterium tuberculosis is estimated to infect 80 to 100 million people annually, the
majority of whom do not develop clinical tuberculosis (TB) but instead maintain the infection in a …

Background. One strategy for improving anti-tuberculosis (TB) vaccination involves the use
of recombinant bacille Calmette-Guérin (rBCG) overexpressing protective TB antigens. …

We describe a test which uses the ability of viable cells to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) to detect resistance to a bactericidal drug, rifampin, …

Tuberculous lymphadenitis (TBLN) is a common form of extrapulmonary tuberculosis with
multiple differential diagnoses. Demonstration of the etiologic agent by smear microscopy or …

Human γ 9 δ 2 T cells potently inhibit pathogenic microbes, including intracellular mycobacteria,
but the key inhibitory mechanism(s) involved have not been identified. We report a …

Mycobacterium tuberculosis and Mycobacterium bovis bacillus Calmette-Guérin (BCG)
induce potent expansions of human memory Vγ 9+ Vδ 2+ T cells capable of IFN-γ production, …

Background Protection from SARS-CoV-2 vaccines wanes over time and is compounded by
emerging variants including Omicron subvariants. This study evaluated safety and …

The colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay
was standardized for direct detection of rifampin-resistant Mycobacterium tuberculosis in …